Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis

Leukotrienes and histamine are both early and late phase mediators in allergic rhinitis. Histamine causes nasal itching, rhinorrhea and sneezing. Leukotrienes cause nasal congestion and rhinorrhea. Montelukast is a potent leukotriene receptor antagonist. Loratadine is a nonsedating antihistamine. Th...

Full description

Bibliographic Details
Main Authors: Murat Yarıktaş, Fehmi Döner, Mehmet Ünlü, Ünal Şahin
Format: Article
Language:English
Published: Galenos Yayincilik 2002-12-01
Series:Turkish Archives of Otorhinolaryngology
Subjects:
Online Access: http://turkarchotolaryngol.net/archives/archive-detail/article-preview/comparison-of-leukotriene-receptor-antagonist-and-/43773
_version_ 1797908168627453952
author Murat Yarıktaş
Fehmi Döner
Mehmet Ünlü
Ünal Şahin
author_facet Murat Yarıktaş
Fehmi Döner
Mehmet Ünlü
Ünal Şahin
author_sort Murat Yarıktaş
collection DOAJ
description Leukotrienes and histamine are both early and late phase mediators in allergic rhinitis. Histamine causes nasal itching, rhinorrhea and sneezing. Leukotrienes cause nasal congestion and rhinorrhea. Montelukast is a potent leukotriene receptor antagonist. Loratadine is a nonsedating antihistamine. The purpose of this study was to determine the effect of montelukast and loratadine in patients with seasonal allergic rhinitis. In this study, 78 patients with seasonal allergic rhinitis were randomly allocated to receive 1 of the following 4 treatments for 20 days: montelukast 10 mg (1st group) (n=20), montelukast 10 mg with loratadine 10 mg (2nd group) (n=19), loratadine 10 mg (3rd group) (n=20) and placebo (4th group) (n=19). Before and after medical treatment, complaint and rhinoscopic findings of patients were compared statistically. Our results showed that concomitant loratadine and montelukast treatment was the most effective therapy among the 4 groups alone. There was no difference between the 1st group and the 3rd group. Second group may provide better relief in allergic rhinitis symptoms. Concomitant antihistamine and leukotriene receptor antagonist usage may provide additive clinical relief for allergic rhinitis.
first_indexed 2024-04-10T10:48:24Z
format Article
id doaj.art-1a2834d95264479fabc4f562ba1b4cd5
institution Directory Open Access Journal
issn 2667-7474
language English
last_indexed 2024-04-10T10:48:24Z
publishDate 2002-12-01
publisher Galenos Yayincilik
record_format Article
series Turkish Archives of Otorhinolaryngology
spelling doaj.art-1a2834d95264479fabc4f562ba1b4cd52023-02-15T16:20:13ZengGalenos YayincilikTurkish Archives of Otorhinolaryngology2667-74742002-12-0140425225613049054Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic RhinitisMurat Yarıktaş0Fehmi Döner1Mehmet Ünlü2Ünal Şahin3 Süleyman Demirel Üniversitesi Tıp Fakültesi Kulak Burun Boğaz Anabilim Dalı Süleyman Demirel Üniversitesi Tıp Fakültesi Kulak Burun Boğaz Anabilim Dalı Süleyman Demirel Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Anabilim Dalı Süleyman Demirel Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Anabilim Dalı Leukotrienes and histamine are both early and late phase mediators in allergic rhinitis. Histamine causes nasal itching, rhinorrhea and sneezing. Leukotrienes cause nasal congestion and rhinorrhea. Montelukast is a potent leukotriene receptor antagonist. Loratadine is a nonsedating antihistamine. The purpose of this study was to determine the effect of montelukast and loratadine in patients with seasonal allergic rhinitis. In this study, 78 patients with seasonal allergic rhinitis were randomly allocated to receive 1 of the following 4 treatments for 20 days: montelukast 10 mg (1st group) (n=20), montelukast 10 mg with loratadine 10 mg (2nd group) (n=19), loratadine 10 mg (3rd group) (n=20) and placebo (4th group) (n=19). Before and after medical treatment, complaint and rhinoscopic findings of patients were compared statistically. Our results showed that concomitant loratadine and montelukast treatment was the most effective therapy among the 4 groups alone. There was no difference between the 1st group and the 3rd group. Second group may provide better relief in allergic rhinitis symptoms. Concomitant antihistamine and leukotriene receptor antagonist usage may provide additive clinical relief for allergic rhinitis. http://turkarchotolaryngol.net/archives/archive-detail/article-preview/comparison-of-leukotriene-receptor-antagonist-and-/43773 allergic rhinitismontelukastloratadine.
spellingShingle Murat Yarıktaş
Fehmi Döner
Mehmet Ünlü
Ünal Şahin
Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
Turkish Archives of Otorhinolaryngology
allergic rhinitis
montelukast
loratadine.
title Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
title_full Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
title_fullStr Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
title_full_unstemmed Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
title_short Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis
title_sort comparison of leukotriene receptor antagonist and antihistamine therapy in seasonal allergic rhinitis
topic allergic rhinitis
montelukast
loratadine.
url http://turkarchotolaryngol.net/archives/archive-detail/article-preview/comparison-of-leukotriene-receptor-antagonist-and-/43773
work_keys_str_mv AT muratyarıktas comparisonofleukotrienereceptorantagonistandantihistaminetherapyinseasonalallergicrhinitis
AT fehmidoner comparisonofleukotrienereceptorantagonistandantihistaminetherapyinseasonalallergicrhinitis
AT mehmetunlu comparisonofleukotrienereceptorantagonistandantihistaminetherapyinseasonalallergicrhinitis
AT unalsahin comparisonofleukotrienereceptorantagonistandantihistaminetherapyinseasonalallergicrhinitis